Back
ProShares UltraShort Nasdaq Biotech Vs. ProShares UltraShort MSCI Emerging Mkts Industry Stock Comparison
Sell
40
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
16.22
Seasonality Move:
-11.25%
Buy
66
EEV
ProShares UltraShort MSCI Emerging Mkts
Last Price:
16.96
Seasonality Move:
-6.96%
Sell
40
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $15.48. The Score for BIS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
ProShares UltraShort MSCI Emerging Mkts (EEV)
is a Buy
Is ProShares UltraShort MSCI Emerging Mkts a Buy, Sell or Hold?
- The current ProShares UltraShort MSCI Emerging Mkts [EEV] share price is $16.98. The Score for EEV is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- EEV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $15.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
EEV Stock Price Chart
What is ProShares UltraShort MSCI Emerging Mkts's stock price today?
-
The ProShares UltraShort MSCI Emerging Mkts share price today is $16.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EEV is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 55.02 | Buy |
| Chaikin Money Flow: | 14190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.74 - 15.56) | Buy |
| Bollinger Bands (100): | (14.55 - 15.91) | Buy |
EEV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 64.02 | Buy |
| Chaikin Money Flow: | 4769 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.04 - 16.1) | Buy |
| Bollinger Bands (100): | (15.43 - 17.93) | Buy |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.96 | Buy |
| 20-day SMA: | 15.18 | Buy |
| 50-day SMA: | 15.13 | Buy |
| 200-day SMA: | 16.65 | Sell |
| 8-day EMA: | 15.06 | Buy |
| 20-day EMA: | 15.13 | Buy |
| 50-day EMA: | 15.19 | Buy |
| 200-day EMA: | 16.62 | Sell |
EEV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.96 | Buy |
| 20-day SMA: | 15.7 | Buy |
| 50-day SMA: | 15.9 | Buy |
| 200-day SMA: | 17.87 | Sell |
| 8-day EMA: | 16.18 | Buy |
| 20-day EMA: | 15.84 | Buy |
| 50-day EMA: | 15.98 | Buy |
| 200-day EMA: | 17.73 | Sell |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort MSCI Emerging Mkts Earnings Growth & EEV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares UltraShort MSCI Emerging Mkts Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||